Apple Other Income (Expense) decreased by 134.7% to -$52.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 81.4%, from -$279.00M to -$52.00M. Over 2 years (FY 2022 to FY 2024), Other Income (Expense) shows an upward trend with a -10.3% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $243.00M | -$247.00M | $160.00M | -$10.00M | -$237.00M | -$393.00M | $64.00M | -$265.00M | $0.00 | -$50.00M | $158.00M | $142.00M | $19.00M | -$248.00M | -$279.00M | -$171.00M | $150.00M | -$52.00M |
| QoQ Change | — | -201.6% | +164.8% | -106.3% | <-999% | -65.8% | +116.3% | -514.1% | +100.0% | — | +416.0% | -10.1% | -86.6% | <-999% | -12.5% | +38.7% | +187.7% | -134.7% |
| YoY Change | — | — | — | -104.1% | — | -59.1% | -60.0% | <-999% | +100.0% | +87.3% | +146.9% | +153.6% | — | -396.0% | -276.6% | -220.4% | +160.5% | +81.4% |